Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

May 9, 2024
BioUtah News
BioHive Live Recap

BioHive Live, BioHive’s inaugural industry-wide event with over 350 registrants took center stage at the Hale Center Theatre in Sandy, Utah on Wednesday. The event featured a series of thought-provoking speakers who engaged, inspired and challenged the audience. Jared Bauer, CEO of Seek Labs and BioHive board chair, welcomed attendees along with Aimee Edwards, BioHive […]

May 9, 2024
BioUtah News
EDWARDS LAUNCHES THE SAPIEN 3 ULTRA RESILIA VALVE IN EUROPE WITH TECHNOLOGY TO ENHANCE DURABILITY

NYON, Switzerland–(BUSINESS WIRE)– Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.* Edwards’ SAPIEN 3 Ultra RESILIA valve recently received CE Mark† for use in patients with heart valve disease […]

May 9, 2024
BioUtah News
Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business

SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the reorganization of its European operations to better align company resources to its domestic opportunities while continuing to serve key biopharma partners and patients outside the United States. As part of […]

May 9, 2024
BioUtah News
Ultradent Announces Acquisition of Ease-In-Shields™ Laser Protection

Ultradent proudly announces the acquisition of Ease-In-Shields™ from ViewMax Solutions, LLC. Ease-In-Shields provides unique eye protection for laser and curing light users, with their double patented shape, allowing the shields to fit into most loupe and eyewear shapes for maximum safety. Of the Ease-in-Shield acquisition, Scot Andersen, Ultradent’s Vice-President of Business Development, said, “After years […]

May 9, 2024
BioUtah News
Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments

SALT LAKE CITY, UT (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced today the successful completion of a therapeutic trial using innovative CRISPR-based technologies to target the African Swine Fever Virus (ASFV) in pigs. The trial, which aimed to replicate and expand […]

May 2, 2024
BioUtah News Policy News
ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices

ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.

May 2, 2024
BioUtah News
Tether Takes Strategic Stake in Leading Brain-Computer-Interface Company Blackrock Neurotech

Tether Takes Strategic Stake in Leading Brain-Computer-Interface Company Blackrock Neurotech

May 2, 2024
BioUtah News
Owlet Announces European Medical Certification of Dream Sock®

Parents will soon have access to Owlet’s Dream Sock with medically-certified CE-Marking across the European markets

May 2, 2024
BioUtah News
Thermo Fisher Scientific Launches New CXCL10 Testing Service

Noninvasive urine-based biomarker testing can support routine testing for graft dysfunction

May 2, 2024
BioUtah News
May 2, 2024
BioUtah News
First adult spine surgery using groundbreaking nView s1 imaging and navigation technology announced

First adult spine surgery using groundbreaking nView s1 imaging and navigation technology announced

May 2, 2024
Policy News
Ingenion Medical Obtains CE Mark for Catheter

The cymactive catheter is the first in a pipeline of urology solutions the UK-based company has planned.

May 2, 2024
BioUtah News
Departing Biochemical Geneticist Leaves Legacy of Scientific Discovery and Devoted Patient Care at ARUP, U of U Health

Nicola Longo, MD, PhD, has spent more than 20 years at University of Utah Health and ARUP Laboratories treating patients in his clinic and working with wife Marzia Pasquali, PhD, FACMG, to advance the diagnosis of inherited metabolic disorders.

May 2, 2024
BioUtah News
SBA Announces 2024 Growth Accelerator Fund Competition Stage One Winners, Up to $3 Million in Prizes Awarded

Competition Opens Doors for Underserved Entrepreneurs in Key Science and Technology Industries

April 25, 2024
BioUtah News
Bluewind Announces Release of Efficacy Data

PARK CITY, Utah, April 23, 2024 /PRNewswire/ — BlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of ReviTM, a patient-centric solution for urge urinary incontinence (UUI), today announced that the peer-reviewed results from the OASIS pivotal trial were published in the Journal of Neurourology and Urodynamics (NAU). OASIS, a prospective, […]

April 25, 2024
BioUtah News
ARUP Partners With ELLKAY to Bring Connectivity Solutions to Health System Outreach Operations

SALT LAKE CITY—ARUP Laboratories and healthcare connectivity company ELLKAY have forged a new partnership aimed at helping health systems establish or expand successful laboratory outreach operations. Hospital laboratories are key contributors to the continuum of care within their communities but often lack the necessary resources to connect provider offices, electronic health records (EHRs), billing departments, […]

April 25, 2024
BioUtah News
Owlet Forges Groundbreaking Partnership with Wheel to Launch Virtual TeleHealth Services Platform

The partnership is set to transform infant care by providing virtual telehealth services to caregivers, increasing access to innovative medical-grade monitoring. LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces a strategic partnership with Wheel, an industry leader in providing virtual patient-centric care. Through this partnership, […]

April 25, 2024
BioUtah News
Epitel Receives FDA 510(k) Clearance for Two New Technologies: REMI Remote EEG Monitoring System for Ambulatory Use and REMI Vigilenz AI For Event Detection

SALT LAKE CITY–(BUSINESS WIRE)–Epitel, a leader in AI technologies for patient-focused brain health solutions, announced today it received U.S. Food and Drug Administration (FDA) 510(k) clearances for two new innovative technologies: REMI™ Remote EEG Monitoring System for Ambulatory (at home) use and REMI Vigilenz™ AI For Event Detection. REMI for Ambulatory use allows EEG recording […]

April 25, 2024
BioUtah News
Joint Warfighter Medical Research Program Opportunity

The Joint Warfighter Medical Research Program (JWMRP) Broad Agency Announcement (BAA) has just opened.

April 18, 2024
BioUtah News
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson & Johnson (J&J), will also join Recursion’s Board of Directors

April 18, 2024
BioUtah News
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer

Company plans to launch FDA IND enabling studies needed to apply for approval to proceed with human trials

April 18, 2024
BioUtah News
One Utah Summit

Utah’s life sciences industry was front and center at this year’s One Utah Summit held April 12, in Salt Lake City, 3 Helix and nView Medical participated in the Startup State Entrepreneur Challenge (see related article). During the afternoon session, Gov. Spencer Cox recognized excellence in several fields handing out the 2024 Governor’s Awards. bioMerieux […]

April 11, 2024
BioUtah News
Co-Diagnostics Opens New Facility in South Salt Lake

Co-Diagnostics (Co-Dx) yesterday held a ribbon-cutting ceremony to celebrate the grand opening of the company’s new manufacturing facility, located at 3222 S. Washington St. in South Salt Lake. South Salt Lake Mayor Cherie Wood, Lance Soffe and Jim Grover with the Governor’s Office of Economic Opportunity, David Carlebach with World Trade Center Utah, representatives from […]

April 11, 2024
BioUtah News
Multiplier partners with Tideline to scale health impact investing

Multiplier Advisors and Tideline today announced a strategic partnership to support health-focused impact investors—such as healthcare organizations, insurers, and foundations—that are directing investable assets to address social determinants of health (SDOH) while targeting the alignment of financial, business, and community impact performance. Through this partnership, Multiplier and Tideline are aiming to unlock $5 billion of […]

April 11, 2024
BioUtah News
Canary Speech And CareLink360 Partner To Support Family Caregivers And The Aging Adults They Care For

Canary Speech and CareLink360 Form Partnership to Support Family Caregivers and the Aging Adults They Care For. Flemington, NJ – April 8, 2024 – Today we are excited to announce a new partnership between Canary Speech, an AI-driven vocal biomarker health company and CareLink360, a digital health, AgeTech, and data analytics insights company, to support family […]

April 11, 2024
BioUtah News
CERVICAL CANCER SCREENING DEVICE WINS ANNUAL BENCH TO BEDSIDE COMPETITION

The C-Blu team’s device provides greater visual contrast to potentially cancerous lesions, enabling improved accuracy for clinicians during the screening process. Despite a crowded field of over 30 other entries, the C-Blu team rose to the top to be named the Grand Prize Winner at the 14th Annual Bench to Bedside Competition on Monday night […]

April 11, 2024
BioUtah News
NUSANO TO PRESENT AT JEFFERIES RADIOPHARMA INNOVATION SUMMIT

VALENCIA, Calif. – April 10, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, today announced it will attend and present at Jefferies Radiopharma Innovation Summit in New York City on Thursday, April 11, 2024. In his presentation, Nusano CEO Chris Lowe will provide an update on the company’s commercialization plans, including […]

April 11, 2024
BioUtah News
Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

Fewer patients were prescribed medications with gene-drug interactions after taking the GeneSight test SALT LAKE CITY, April 09, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, revealed results from a multi-year, real-world study of nearly 21,000 patients that indicated those with major depressive disorder had reduced […]

April 11, 2024
BioUtah News
Renalytix Announces Financing with Expected Size of up to $4 Million

LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces a registered direct offering of ordinary shares at a purchase price equivalent to $0.75 per NASDAQ ADS ($0.375 per common stock share) (£0.0025 each) (the “Ordinary Shares”) (the “Fundraise”) to DB Capital Partners Healthcare, L.P. (the “Purchaser”), […]

April 11, 2024
BioUtah News
BD Named a Best Employer for Excellence in Employee Well-Being

FRANKLIN LAKES, N.J., April 9, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health “Best Employers: Excellence in Health & Well-being Award” for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives. BD also […]

April 11, 2024
BioUtah News
STUDY OF NFL ALUMNI COHORT FINDS MAJORITY SUFFER FROM HEART DISEASE WITHOUT KNOWING IT

ATLANTA–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members of the National Football League (NFL) Alumni Association and their families. The findings of this study, which identified a significant discrepancy between participant self-awareness and actual prevalence […]

April 11, 2024
BioUtah News
Leash Biosciences Announces $9.3 Million Seed Financing to Pioneer AI-Driven Medicinal Chemistry

– Financing will support development of a foundational machine learning model of medicinal chemistry that can accurately predict small molecule drug candidates for any protein – – Releases unprecedented dataset publicly to address critical challenges in drug discovery with machine learning – SALT LAKE CITY, April 05, 2024 (GLOBE NEWSWIRE) — Leash Biosciences, an artificial […]